...
首页> 外文期刊>Arthritis & Rheumatism >S100A8 causes a shift toward expression of activatory Fc receptors on macrophages via toll-like receptor 4 and regulates Fc receptor expression in synovium during chronic experimental arthritis
【24h】

S100A8 causes a shift toward expression of activatory Fc receptors on macrophages via toll-like receptor 4 and regulates Fc receptor expression in synovium during chronic experimental arthritis

机译:S100A8导致通过Toll样受体4向巨噬细胞上的活化Fc受体表达转移,并在慢性实验性关节炎期间调节滑膜中Fc受体表达

获取原文
获取原文并翻译 | 示例

摘要

ObjectiveThe levels of both Fc receptor (FcR) and the alarmins S100A8 and S100A9 are correlated with the development and progression of cartilage destruction during antigen-induced arthritis (AIA). This study was undertaken to study the active involvement of S100A8, S100A9, and S100A8/S100A9 in FcR regulation in murine macrophages and synovium during AIA.MethodsRecombinant murine S100A8 (rS100A8) was injected into normal mouse knee joints, and the synovium was isolated for analysis of FcR messenger RNA (mRNA) expression by reverse transcription–polymerase chain reaction (RT-PCR). Macrophages, including bone marrow macrophages derived from Toll-like receptor 4–deficient (TLR-4−/−) mice, and polymorphonuclear cells (PMNs) were stimulated with S100 proteins, and levels of FcR mRNA and protein were measured using RT-PCR and fluorescence-activated cell sorting analyses. AIA was induced in the knee joints of S100A9-deficient (S100A9−/−) mice, compared with wild-type (WT) controls, and the extent of cartilage destruction was determined using immunohistochemical analysis.ResultsIntraarticular injection of rS100A8 into the knee joints of normal mice caused a strong up-regulation of mRNA levels of activating FcRI (64-fold increase) and FcRIV (256-fold increase) in the synovium. Stimulation of macrophages with rS100A8 led to significant up-regulation of mRNA and protein levels of FcRI and FcRIV, but not FcRIII, while the effects of S100A9 or S100A8/S100A9 complexes were less potent. Stimulation of PMNs (32Dcl3 cell line) with S100 proteins had no effect on FcR expression. Up-regulation of FcRI and FcRIV was abrogated in rS100A8-stimulated macrophages from TLR-4−/− mice, indicating that the induction of FcR expression by S100A8 is mediated by TLR-4. FcR expression in the inflamed synovium of S100A9−/− mice was significantly lower on day 14 after arthritis induction when compared with WT controls, and these findings correlated with reduced severity of matrix metalloproteinase–mediated cartilage destruction.ConclusionS100A8 is a strong promoter of activating FcRI and FcRIV in macrophages through the activation of TLR-4, and acts as a regulator of FcR expression in inflamed synovium in chronic experimental arthritis.
机译:目的Fc受体(FcR)和警报蛋白S100A8和S100A9的水平与抗原诱导的关节炎(AIA)期间软骨破坏的发生和发展相关。本研究旨在研究A100期间S100A8,S100A9和S100A8 / S100A9在小鼠巨噬细胞和滑膜中的FcR调控中的作用。逆转录聚合酶链反应(RT-PCR)检测FcR信使RNA(mRNA)的表达。用S100蛋白刺激巨噬细胞,包括来源于Toll样受体4缺陷(TLR-4 -/-)小鼠的骨髓巨噬细胞和多形核细胞(PMN),以及FcR mRNA和使用RT-PCR和荧​​光激活细胞分选分析来测量蛋白质。与野生型(WT)对照组相比,S100A9缺陷型(S100A9 -/-)小鼠的膝关节会诱发AIA,并通过免疫组织化学分析确定了软骨破坏的程度。 rS100A8进入正常小鼠膝关节后,导致滑膜中激活FcRI(增加64倍)和FcRIV(增加256倍)的mRNA水平强烈上调。用rS100A8刺激巨噬细胞导致FcRI和FcRIV的mRNA和蛋白水平显着上调,但FcRIII则不明显,而S100A9或S100A8 / S100A9复合物的作用效果较差。用S100蛋白刺激PMN(32Dcl3细胞系)对FcR表达没有影响。在来自TLR-4 -/-小鼠的rS100A8刺激的巨噬细胞中,FcRI和FcRIV的上调被取消,这表明S100A8对FcR表达的诱导是由TLR-4介导的。与野生型对照组相比,在诱导关节炎后第14天,S100A9 -/-小鼠发炎滑膜中的FcR表达显着降低,并且这些发现与基质金属蛋白酶介导的软骨破坏的严重程度降低有关。 TNF-α是通过激活TLR-4激活巨噬细胞中的FcRI和FcRIV的强启动子,并在慢性实验性关节炎的发炎滑膜中充当FcR表达的调节剂。

著录项

  • 来源
    《Arthritis & Rheumatism》 |2010年第11期|p.3353-3364|共12页
  • 作者单位

    Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;

    Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;

    Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;

    Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;

    Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;

    Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;

    Universittsklinikum Muenster and University of Muenster, Muenster, Germany;

    Universittsklinikum Muenster and University of Muenster, Muenster, Germany;

    Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号